Trevor F. Carr

Use of Enzyme Replacement Therapy (Laronidase) before Hematopoietic Stem Cell Transplantation for Mucopolysaccharidosis I: Experience in 18 Patients

Robert Wynn, Jean Mercer, Joanne Page et al. · The Journal of Pediatrics · 2008 · 85 citations

Transplantation, Marrow Transplantation, Enzyme Replacement Therapy +4

Treosulfan‐containing regimens achieve high rates of engraftment associated with low transplant morbidity and mortality in children with non‐malignant disease and significant co‐morbidities

Brigit Greystoke, Sonia Bonanomi, Trevor F. Carr et al. · British Journal of Haematology · 2008 · 62 citations

Total Treosulfan Dose, Transplantation, Marrow Transplantation +15

Improved Outcome From Invasive Adenovirus Infection in Pediatric Patients After Hemopoietic Stem Cell Transplantation Using Intensive Clinical Surveillance and Early Intervention

Ponni Sivaprakasam, Trevor F. Carr, Mary Coussons et al. · Journal of Pediatric Hematology/Oncology · 2007 · 50 citations

Invasive Adenovirus Infection, Transplantation, Pediatric Hematology +14

Retrovirally mediated correction of bone marrow–derived mesenchymal stem cells from patients with mucopolysaccharidosis type I

M. Baxter, Robert Wynn, Jonathan A. Deakin et al. · Blood · 2002 · 42 citations · Full text

The impact of monitoring Epstein–Barr virus PCR in paediatric bone marrow transplant patients: Can it successfully predict outcome and guide intervention?

Hayley M. Greenfield, Maged I. Gharib, Andrew Turner et al. · Pediatric Blood & Cancer · 2005 · 37 citations